Skip to main content

Advertisement

ADVERTISEMENT

Department

Conference Insider
05/10/2017
According to an award-winning poster presented at the AMCP 2017 Annual Meeting, integration of a clinical pharmacist into a managed care plan helped to significantly reduce both medical and pharmacy costs by optimizing drug utilization. 
According to an award-winning poster presented at the AMCP 2017 Annual Meeting, integration of a clinical pharmacist into a managed care plan helped to significantly reduce both medical and pharmacy costs by optimizing drug utilization. 
According to an award-winning...
05/10/2017
First Report Managed Care

Advertisement

Conference Insider
05/10/2017
According to research presented at the AMCP 2017 Annual Meeting, Zarxio (filgrastim-sndz; Sandoz) cost savings, predicted using a budget impact model, failed to meet the expectations of researchers due to the drug’s higher price.
According to research presented at the AMCP 2017 Annual Meeting, Zarxio (filgrastim-sndz; Sandoz) cost savings, predicted using a budget impact model, failed to meet the expectations of researchers due to the drug’s higher price.
According to research presented...
05/10/2017
First Report Managed Care
Conference Insider
05/10/2017
According to research presented at the AMCP 2017 Annual Meeting, Medicaid formulary approaches generally lead branded drugs to become more expensive after a generic competitor is released. This cost trend runs counter to the expected trend...
According to research presented at the AMCP 2017 Annual Meeting, Medicaid formulary approaches generally lead branded drugs to become more expensive after a generic competitor is released. This cost trend runs counter to the expected trend...
According to research presented...
05/10/2017
First Report Managed Care
Conference Insider
05/10/2017
According to an award-winning poster presented at the AMCP 2017 Annual Meeting, Trulance (plecanatide; Synergy) significantly reduced bowel symptoms and improved quality of life for patients with chronic idiopathic constipation.
According to an award-winning poster presented at the AMCP 2017 Annual Meeting, Trulance (plecanatide; Synergy) significantly reduced bowel symptoms and improved quality of life for patients with chronic idiopathic constipation.
According to an award-winning...
05/10/2017
First Report Managed Care

Advertisement

Conference Insider
05/10/2017
During a presentation at the AMCP 2017 Annual Meeting, Aimee Tharaldson, PharmD, senior clinical consultant in the Emerging Therapeutics department at Express Scripts, updated managed care professionals on the upcoming specialty pharmacy...
During a presentation at the AMCP 2017 Annual Meeting, Aimee Tharaldson, PharmD, senior clinical consultant in the Emerging Therapeutics department at Express Scripts, updated managed care professionals on the upcoming specialty pharmacy...
During a presentation at the...
05/10/2017
First Report Managed Care
Conference Insider
05/10/2017
In one survey of payers, 47.6% reported having pathways for multiple myeloma, with another 19.1% citing the cancer type as a high priority for pathway development, Edmund Pezalla, MD, MPH, chief executive officer of Enlightenment BioConsult,...
In one survey of payers, 47.6% reported having pathways for multiple myeloma, with another 19.1% citing the cancer type as a high priority for pathway development, Edmund Pezalla, MD, MPH, chief executive officer of Enlightenment BioConsult,...
In one survey of payers, 47.6%...
05/10/2017
First Report Managed Care
Conference Insider
05/10/2017
During a presentation at the AMCP 2017 Annual Meeting, Aimee Tharaldson, PharmD, senior clinical consultant in the Emerging Therapeutics department at Express Scripts, updated managed care professionals on the upcoming specialty pharmacy...
During a presentation at the AMCP 2017 Annual Meeting, Aimee Tharaldson, PharmD, senior clinical consultant in the Emerging Therapeutics department at Express Scripts, updated managed care professionals on the upcoming specialty pharmacy...
During a presentation at the...
05/10/2017
First Report Managed Care

Advertisement

News Connection
04/19/2017
The FDA granted fast track designation for NKTR-181 (Nektar), a first-in-class opioid analgesic, designed to relieve pain while significantly lowering the risk for abuse compared  with oxycodone, according to a press release from the...
The FDA granted fast track designation for NKTR-181 (Nektar), a first-in-class opioid analgesic, designed to relieve pain while significantly lowering the risk for abuse compared  with oxycodone, according to a press release from the...
The FDA granted fast track...
04/19/2017
First Report Managed Care
News Connection
04/19/2017
Dupixent Injection received approval from the FDA for the treatment of adults with atopic dermatitis not adequately controlled with topical prescription therapies.
Dupixent Injection received approval from the FDA for the treatment of adults with atopic dermatitis not adequately controlled with topical prescription therapies.
Dupixent Injection received...
04/19/2017
First Report Managed Care
News Connection
04/19/2017
The FDA recently approved Ocrevus (ocrelizumab; Roche) for both relapsing and primary progressive forms of multiple sclerosis (MS). Ocrevus is the first disease-modifying therapy approved to treat primary progressive MS, one of the most...
The FDA recently approved Ocrevus (ocrelizumab; Roche) for both relapsing and primary progressive forms of multiple sclerosis (MS). Ocrevus is the first disease-modifying therapy approved to treat primary progressive MS, one of the most...
The FDA recently approved...
04/19/2017
First Report Managed Care

Advertisement

Advertisement